Automated Conditional Statements Checking for Complete Natural Language Requirements Specification

by Chun Liu, Zhengyi Zhao, Lei Zhang, Zheng Li
Published 2021-08-01

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma

by Jie Wang, Zhijie Wang, Jianchun Duan, Rui Wan, Jiachen Xu, Kailun Fei, Chengcheng Li, Wenzhuan Xie, Zhengyi Zhao, Shangli Cai
Published 2020-07-01

Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan‐cancer analysis

by Dong Shen, Junling Zhang, Kai Yuan, Jing Zhao, Zhengyi Zhao, Longgang Cui, Yuzi Zhang, Guoqiang Wang, Shangli Cai, Yuezong Bai, Wei Li, Xiang Huang
Published 2021-08-01

Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer

by Wenjuan Tian, Boer Shan, Yuzi Zhang, Yulan Ren, Shanhui Liang, Jing Zhao, Zhengyi Zhao, Guoqiang Wang, Xiaochen Zhao, Dongxian Peng, Rui Bi, Shangli Cai, Yuezong Bai, Huaying Wang
Published 2020-03-01

Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy

by Fan Zhang, Di Huang, Lei Zhao, Tao Li, Sujie Zhang, Guoqing Zhang, Fang Yuan, Jie Zhang, Yuzi Zhang, Zhengyi Zhao, Longgang Cui, Jing Zhao, Guoqiang Wang, Shangli Cai, Yuezong Bai, Jinliang Wang, Yi Hu
Published 2020-07-01

Everolimus‐containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study

by Zhanhong Chen, Yabing Zheng, Wenming Cao, Yuzi Zhang, Zhengyi Zhao, Guoqiang Wang, Jing Zhao, Shangli Cai, Xiying Shao, Jian Huang, Weiwu Ye, Yuan Huang, Wei Li, Xiang Huang, Hao Wu, Xiaojia Wang, Yongmei Yin
Published 2019-09-01